Singapore
KROSSLINKER Aerogel Solutions is transforming the insulation landscape with its innovative application of Aerogel technology. Founded in 2019 and headquartered in Singapore, the company is carving a niche in the Biopharma, Biotechnology, Manufacturing, and Pharmaceutical sectors. Their initial focus is on revolutionizing cold-chain biopharma packaging by safeguarding temperature-sensitive pharmaceuticals, biologics, and vaccines during transport.
With the slogan "Discover the Power of Insulation," KROSSLINKER is poised to lead in industries that demand enhanced thermal protection. The company has yet to secure its last disclosed funding round, presenting a compelling opportunity for investors to engage with a market-disruptive player. Positioned at the intersection of high-tech innovation and crucial industry needs, KROSSLINKER's growth potential makes it a key candidate for venture capital interest.
